Bio-imaging Market Scope 2031
The Bio-imaging Market is expected to register a CAGR of 5.4 % from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented Technology (Medical and Molecular). Further, the report is segmented on the basis of End User (Diagnostic Centers and Hospitals) The global analysis is further broken-down at regional level and major countries. The report offers the value in USD for the above analysis and segments.
Purpose of the ReportThe report Bio-imaging Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Bio-imaging Market Segmentation
Technology- Medical and Molecular
- Diagnostic Centers and Hospitals
Strategic Insights
Bio-imaging Market Growth Drivers- Upsurge in the Need for Early Diagnosis: There is a growing need for early diagnosis of several ailments, which is one of the major propellers for the bio-imaging market. Healthcare providers understand that treating diseases such as cancer or cardiovascular systems in their early stage renders more positive results than attending to them later. Given that patients and clinicians alike are shifting focus to early intervention, there is an influx of advanced imaging systems that allow for early and easy diagnosis of ailments.
- Increase in the use of Advanced Imaging Technology: The bio-imaging market is being driven by the rapid advancement of imaging equipment that uses techniques such as high resolution MRI, better ultrasound, and molecular imaging technology. These are further developments that enable health professionals to obtain better images which are more defined for excellent diagnosis and treatment patterns. With the passage of time, these technologies keep developing themselves and they also enable the clinicians more making bio-imaging impossible to miss in the present day medical practice.
- Increasing Aging Population: The growing aging population across the global continent is one of the major factors that encourage the growth of bio-imaging market. This is because older persons are more vulnerable to chronic illnesses or conditions that also deteriorate with age which makes them more dependent on constant diagnosis and advanced treatment procedures. In this regard, geriatric population boom leads to the search for viable bio-imaging options as management of healthcare systems for the elderly focuses on offering quality services.
- Invasion of Artificial Intelligence : The integration of artificial intelligence in the field of bio-imaging is enhancing medical diagnosis by improving the analysis and interpretation of images. AI techniques are programmed to search rapidly for patterns and irregularities and do it very successfully and fast. This seems to promote the use of image processing techniques within automated systems, thus decreasing the workload on radiologists and allowing for quicker turnaround times. It goes without saying that as Artificial Intelligence gets better, it will aid efficiency in Bio-imaging processes and in results for the patients as well.
- Point-of-Care Imaging Solutions : The emergence of point-of-care imaging solutions is significantly improving the diagnosis of various health conditions in different healthcare facilities. For instance, within the range of portable imaging devices, one can find handheld ultrasound machines which allow for immediate assessment and decision- making, especially in cases of emergency or in hard to reach areas. Such a trend increases availability of imaging services and reduces the time for waiting which therefore enhances patient care by helping to make changes based upon recent information quickly.
- Focus on the Growth of Personalized Medicine: Personalized medicine is gaining more popularity, and that is one of the factors that has contributed to the development of innovations in bio-imaging technologies focused on specific patients. There are some advanced imaging methods that can help appreciate the different features of a disease which helps in designing disease specific therapy. This trend not only enhances the ability to make a correct diagnosis but also aims at improving the effectiveness of treatment resulting in the shift from population health management to healthcare that cares about patients as individuals and actively seeks to modify interventions and outcomes according to individual patients.
- Growth Opportunities Within Emerging Economies : Emerging economies are becoming potential growth hotspots for the bio-imaging industry. As the healthcare system becomes better and the availability of modern equipment becomes widespread, diagnostic imaging services are expected to grow. This trend can be leveraged by forming collaboration with local players and modifying their offerings in accordance with these countries for better utilization and penetration into the country’s market.Incorporation of Artificial Intelligence: The incorporation of artificial intelligence (AI) in bio-imaging is a game changer. AI can help in image interpretation, help in carrying out certain functions and assist in making diagnoses. In essence by creating imaging solutions which employ the use of AI technology in its operation, such companies will tackle the notions of overworking the health care providers, enhancement of the patients scenarios and competition in the sector thus making room for new ideas and business expansion.Efforts Towards Personalized Medicine : Given its focus on more specialized diagnostic techniques, the gynecological imaging market is shifting towards personalized medicine, which brought some opportunities. The latest approaches to imaging technology can reveal the details of each patient profile for treatment mechanisms, and thus appropriate therapies can be employed, making the treatment easier. Imaging strategies can be adapted to the growing of such personalized medicine and the healing system as well, and the companies developing those strategies will ensure their position in the streets dressed in a balaclava and looking quite dangerous.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Bio-imaging Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Bio-imaging Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORKHave a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Increasing number of diagnostic centers and radiopharmaceutics is the factor driving market growth
BioClinica, Inc.
, Bracco Imaging S.p.A
, FONAR Corporation are the key players operating in the bio-imaging market
The report can be delivered in PDF/Word format, we can also share excel data sheet based on request.
Medical segment accounts for highest revenue in product type in the market in 2023
Based on geography, Asia Pacific held the largest share of the bio-imaging market.
The Bio-imaging Market is estimated to witness a CAGR of 5.4 % from 2023 to 2031
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Bio-imaging Market - By Technology
1.3.2 Bio-imaging Market - By End User
1.3.3 Bio-imaging Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. BIO-IMAGING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BIO-IMAGING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. BIO-IMAGING MARKET - GLOBAL MARKET ANALYSIS
6.1. BIO-IMAGING - GLOBAL MARKET OVERVIEW
6.2. BIO-IMAGING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. BIO-IMAGING MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. MEDICAL AND MOLECULAR
7.3.1. Overview
7.3.2. Medical and Molecular Market Forecast and Analysis
8. BIO-IMAGING MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. DIAGNOSTIC CENTERS AND HOSPITALS.
8.3.1. Overview
8.3.2. Diagnostic Centers and Hospitals. Market Forecast and Analysis
9. BIO-IMAGING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Bio-imaging Market Overview
9.1.2 North America Bio-imaging Market Forecasts and Analysis
9.1.3 North America Bio-imaging Market Forecasts and Analysis - By Technology
9.1.4 North America Bio-imaging Market Forecasts and Analysis - By End User
9.1.5 North America Bio-imaging Market Forecasts and Analysis - By Countries
9.1.5.1 United States Bio-imaging Market
9.1.5.1.1 United States Bio-imaging Market by Technology
9.1.5.1.2 United States Bio-imaging Market by End User
9.1.5.2 Canada Bio-imaging Market
9.1.5.2.1 Canada Bio-imaging Market by Technology
9.1.5.2.2 Canada Bio-imaging Market by End User
9.1.5.3 Mexico Bio-imaging Market
9.1.5.3.1 Mexico Bio-imaging Market by Technology
9.1.5.3.2 Mexico Bio-imaging Market by End User
9.1.5.4 US Bio-imaging Market
9.1.5.4.1 US Bio-imaging Market by Technology
9.1.5.4.2 US Bio-imaging Market by End User
9.2. EUROPE
9.2.1 Europe Bio-imaging Market Overview
9.2.2 Europe Bio-imaging Market Forecasts and Analysis
9.2.3 Europe Bio-imaging Market Forecasts and Analysis - By Technology
9.2.4 Europe Bio-imaging Market Forecasts and Analysis - By End User
9.2.5 Europe Bio-imaging Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Bio-imaging Market
9.2.5.1.1 Germany Bio-imaging Market by Technology
9.2.5.1.2 Germany Bio-imaging Market by End User
9.2.5.2 France Bio-imaging Market
9.2.5.2.1 France Bio-imaging Market by Technology
9.2.5.2.2 France Bio-imaging Market by End User
9.2.5.3 Italy Bio-imaging Market
9.2.5.3.1 Italy Bio-imaging Market by Technology
9.2.5.3.2 Italy Bio-imaging Market by End User
9.2.5.4 Spain Bio-imaging Market
9.2.5.4.1 Spain Bio-imaging Market by Technology
9.2.5.4.2 Spain Bio-imaging Market by End User
9.2.5.5 United Kingdom Bio-imaging Market
9.2.5.5.1 United Kingdom Bio-imaging Market by Technology
9.2.5.5.2 United Kingdom Bio-imaging Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Bio-imaging Market Overview
9.3.2 Asia-Pacific Bio-imaging Market Forecasts and Analysis
9.3.3 Asia-Pacific Bio-imaging Market Forecasts and Analysis - By Technology
9.3.4 Asia-Pacific Bio-imaging Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Bio-imaging Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Bio-imaging Market
9.3.5.1.1 Australia Bio-imaging Market by Technology
9.3.5.1.2 Australia Bio-imaging Market by End User
9.3.5.2 China Bio-imaging Market
9.3.5.2.1 China Bio-imaging Market by Technology
9.3.5.2.2 China Bio-imaging Market by End User
9.3.5.3 India Bio-imaging Market
9.3.5.3.1 India Bio-imaging Market by Technology
9.3.5.3.2 India Bio-imaging Market by End User
9.3.5.4 Japan Bio-imaging Market
9.3.5.4.1 Japan Bio-imaging Market by Technology
9.3.5.4.2 Japan Bio-imaging Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Bio-imaging Market Overview
9.4.2 Middle East and Africa Bio-imaging Market Forecasts and Analysis
9.4.3 Middle East and Africa Bio-imaging Market Forecasts and Analysis - By Technology
9.4.4 Middle East and Africa Bio-imaging Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Bio-imaging Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Bio-imaging Market
9.4.5.1.1 South Africa Bio-imaging Market by Technology
9.4.5.1.2 South Africa Bio-imaging Market by End User
9.4.5.2 Saudi Arabia Bio-imaging Market
9.4.5.2.1 Saudi Arabia Bio-imaging Market by Technology
9.4.5.2.2 Saudi Arabia Bio-imaging Market by End User
9.4.5.3 U.A.E Bio-imaging Market
9.4.5.3.1 U.A.E Bio-imaging Market by Technology
9.4.5.3.2 U.A.E Bio-imaging Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Bio-imaging Market Overview
9.5.2 South and Central America Bio-imaging Market Forecasts and Analysis
9.5.3 South and Central America Bio-imaging Market Forecasts and Analysis - By Technology
9.5.4 South and Central America Bio-imaging Market Forecasts and Analysis - By End User
9.5.5 South and Central America Bio-imaging Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Bio-imaging Market
9.5.5.1.1 Brazil Bio-imaging Market by Technology
9.5.5.1.2 Brazil Bio-imaging Market by End User
9.5.5.2 Argentina Bio-imaging Market
9.5.5.2.1 Argentina Bio-imaging Market by Technology
9.5.5.2.2 Argentina Bio-imaging Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. BIO-IMAGING MARKET, KEY COMPANY PROFILES
11.1. BIOCLINICA, INC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BRACCO IMAGING S.P.A
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. FONAR CORPORATION
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BAYER HEALTHCARE PHARMACEUTICALS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. COVIDIEN PHARMACEUTICALS
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. DIGIRAD CORPORATION
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ESAOTE S.P.A
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. HITACHI MEDICAL CORPORATION
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. GAMMA MEDICA INC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. GE HEALTHCARE
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
- BioClinica, Inc.
- Bracco Imaging S.p.A
- FONAR Corporation
- Bayer HealthCare Pharmaceuticals
- Covidien Pharmaceuticals
- Digirad Corporation
- Esaote S.p.A
- Hitachi Medical Corporation
- Gamma Medica Inc.
- GE Healthcare
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.